Postmenopausal hormone replacement therapy.
作者信息
Noble A
出版信息
BMJ. 1993 Jan 23;306(6872):270. doi: 10.1136/bmj.306.6872.270-a.
Abstract
摘要
相似文献
1
Postmenopausal hormone replacement therapy.绝经后激素替代疗法
BMJ. 1993 Jan 23;306(6872):270. doi: 10.1136/bmj.306.6872.270-a.
2
Hormone replacement therapy: optimising the dose and route of administration.激素替代疗法：优化剂量与给药途径
Drugs Aging. 2002;19(11):807-18. doi: 10.2165/00002512-200219110-00001.
3
Optimizing the dose of hormone replacement therapy.优化激素替代疗法的剂量。
Int J Fertil Womens Med. 2002 Sep-Oct;47(5):205-10.
4
Treatment of Turner's syndrome--a concern.特纳综合征的治疗——一个值得关注的问题。
Lancet. 1996 Sep 7;348(9028):681-2. doi: 10.1016/s0140-6736(05)65102-1.
5
Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women.激素疗法能否改善绝经后女性与年龄相关的皮肤变化？一项随机、双盲、双模拟、安慰剂对照的多中心研究，评估醋酸炔诺酮和炔雌醇对改善绝经后女性轻度至中度与年龄相关皮肤变化的效果。
J Am Acad Dermatol. 2008 Sep;59(3):397-404.e3. doi: 10.1016/j.jaad.2008.05.009. Epub 2008 Jul 14.
6
Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study.联合使用炔雌醇/醋酸炔诺酮不能改善有心血管事件风险的绝经后女性的前臂血流量：一项初步研究。
J Womens Health (Larchmt). 2007 Sep;16(7):963-70. doi: 10.1089/jwh.2006.0321.
7
[Kallikrein concentration in mixed saliva after contraceptive administration or postmenopausal hormone replacement].
Laryngorhinootologie. 1998 Sep;77(9):521-4. doi: 10.1055/s-2007-997017.
8
Recurrent pelvic endometriosis and bilateral ureteric obstruction associated with hormone replacement therapy.复发性盆腔子宫内膜异位症及与激素替代疗法相关的双侧输尿管梗阻
BMJ. 1996 May 11;312(7040):1221-2. doi: 10.1136/bmj.312.7040.1221.
9
Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.雌激素替代疗法的口服和经皮给药途径对绝经后妇女24小时生长激素（GH）分泌、胰岛素样生长因子I及GH结合蛋白的对比作用。
J Clin Endocrinol Metab. 1991 Feb;72(2):374-81. doi: 10.1210/jcem-72-2-374.
10
Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone.绝经后激素替代疗法与心血管疾病：经皮雌二醇和微粒化孕酮的价值。
Climacteric. 2012 Apr;15 Suppl 1:11-7. doi: 10.3109/13697137.2012.669624.
本文引用的文献
1
Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study.绝经后雌激素使用、吸烟与50岁以上女性的心血管疾病发病率。弗雷明汉姆研究。
N Engl J Med. 1985 Oct 24;313(17):1038-43. doi: 10.1056/NEJM198510243131702.
2
The risk of breast cancer after estrogen and estrogen-progestin replacement.雌激素及雌孕激素替代治疗后患乳腺癌的风险。
N Engl J Med. 1989 Aug 3;321(5):293-7. doi: 10.1056/NEJM198908033210505.
3
Estrogen replacement therapy and the risk of venous thrombosis.雌激素替代疗法与静脉血栓形成风险
Am J Med. 1992 Mar;92(3):275-82. doi: 10.1016/0002-9343(92)90077-o.
4
Postmenopausal hormone replacement therapy.绝经后激素替代疗法
BMJ. 1992 Dec 5;305(6866):1403-8. doi: 10.1136/bmj.305.6866.1403.
Zotero 插件